0001815337-21-000001.txt : 20210917 0001815337-21-000001.hdr.sgml : 20210917 20210917162102 ACCESSION NUMBER: 0001815337-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210917 DATE AS OF CHANGE: 20210917 EFFECTIVENESS DATE: 20210917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Santi Therapeutics, Inc. CENTRAL INDEX KEY: 0001815337 IRS NUMBER: 843078067 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-413815 FILM NUMBER: 211260676 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR STREET 2: C/O RA CAPITAL CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2572 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR STREET 2: C/O RA CAPITAL CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001815337 Santi Therapeutics, Inc. 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 617-778-2572 DELAWARE None None Corporation true 2019 Milind Deshpande 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Joshua Resnick 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director David Grayzel 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Simon Read 400 Tottten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Pharmaceuticals Decline to Disclose 06b false 2021-09-03 false true false 0 10000000 10000000 0 false 1 0 0 0 false Santi Therapeutics, Inc. Milind Deshpande Milind Deshpande President 2021-09-17